Testosterone therapy does not affect coagulation in male hypogonadism: a longitudinal study based on thrombin generation.

Valeria LanziRita IndirliArmando TripodiMarigrazia ClericiMarco Bonomi Biagio CangianoIulia PetriaArosio Maura Mantovani Giovanna Emanuele Ferrante

Published in: The Journal of clinical endocrinology and metabolism (2024)

Hypogonadal men display a procoagulant imbalance detected by increased thrombin generation. Short-term TRT does not worsen global coagulation, suggesting that the treatment can be safely prescribed to men diagnosed with hypogonadism.

Keyphrases

replacement therapy
smoking cessation
middle aged
stem cells
bone marrow
mesenchymal stem cells
cell therapy